Treatment Efficacy of Pharmacotherapies for Frontotemporal Dementia: A Network Meta-Analysis of Randomized Controlled Trials

Huang, Mao-HsuanMao-HsuanHuangZeng, Bing-SyuanBing-SyuanZengTseng, Ping-TaoPing-TaoTsengHsu, Chih-WeiChih-WeiHsuWu, Yi-ChengYi-ChengWuYU-KANG TUStubbs, BrendonBrendonStubbsCarvalho, Andre FAndre FCarvalhoLiang, Chih-SungChih-SungLiangChen, Tien-YuTien-YuChenChen, Yen-WenYen-WenChenSu, Kuan-PinKuan-PinSu2024-01-172024-01-172023-1210647481https://scholars.lib.ntu.edu.tw/handle/123456789/638580The neuropsychiatric symptoms of frontotemporal dementia (FTD) have a profound negative impact on disease outcomes and care burden. Available pharmacotherapies might be supported by small-scale randomized controlled trials (RCTs); however, clinical recommendations might not be conclusive.enDrug; major neurocognitive disorder; medication; oxytocin; systematic reviewTreatment Efficacy of Pharmacotherapies for Frontotemporal Dementia: A Network Meta-Analysis of Randomized Controlled Trialsjournal article10.1016/j.jagp.2023.06.013376337622-s2.0-85169073250https://api.elsevier.com/content/abstract/scopus_id/85169073250